Supplementary Information for "Biologics for Severe, Chronic Plaque Psoriasis: A Cost-Utility Analysis"

Mendeley Data2021-04-13 更新2026-04-09 收录

药物经济学评估

银屑病治疗

数据链接：

https://data.mendeley.com/datasets/79b2ns555y 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Information for "Biologics for Severe, Chronic Plaque Psoriasis: A Cost-Utility Analysis"

创建时间：

2021-04-13

The Patient’s Guide to Psoriasis Treatment. Part 1: UVB Phototherapy

银屑病治疗

UVB光疗

Article full text The full text of this article can be found here . https://link.springer.com/article/10.1007/s13555-016-0129-2 The full text of all of the articles in this Topi

DataCite Commons2020-08-30 更新150

Supplementary Material for: Efficacy of Calcipotriol-Betamethasone Ointment in Patients with Mild to Moderate Plaque Psoriasis: Subgroup Analyses

银屑病治疗

药物疗效分析

Background: Several factors have been shown to affect psoriasis pathogenesis, clinical presentation and treatment response. Objectives: The aim of this study was to investi

DataCite Commons2025-06-01 更新60

Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study

药物经济学评估

肺癌靶向治疗可及性

ABSTRACT BACKGROUND: Lung cancer is the fourth most common cancer in Brazil. In the 2000s, better understanding of molecular pathways led to development of epidermal growth factor receptor (EGFR)-ta

NIAID Data Ecosystem20

Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study - supplementary table

心衰治疗成本分析

药物经济学评估

Aim: Compare heart failure (HF) costs of Furoscix use at home compared with inpatient intravenous (IV) diuresis. Patients & methods: Prospective, case control study of chronic HF pat

DataCite Commons2024-05-17 更新100

Oral JAK Inhibitors in the Management of Nail Psoriasis: An Evidence Based Review

银屑病治疗

JAK抑制剂疗效

Nail psoriasis is a manifestation of psoriasis localized to the nails, often presenting with pitting, onycholysis, and subungual hyperkeratosis. Currently, there are no FDA approved treatments specifi

Mendeley Data50

Supplementary Information for "Biologics for Severe, Chronic Plaque Psoriasis: A Cost-Utility Analysis"

资源简介：

相关数据集